CDCRX
Price
$10.99
Change
+$0.08 (+0.73%)
Updated
May 8 closing price
Net Assets
29.81M
FSMAX
Price
$85.16
Change
+$1.54 (+1.84%)
Updated
May 8 closing price
Net Assets
36.02B
Ad is loading...

CDCRX vs FSMAX

Header iconCDCRX vs FSMAX Comparison
Open Charts CDCRX vs FSMAXBanner chart's image
Copeland Dividend Growth Fund
Price$10.99
Change+$0.08 (+0.73%)
VolumeN/A
Net Assets29.81M
Fidelity Extended Market Index
Price$85.16
Change+$1.54 (+1.84%)
VolumeN/A
Net Assets36.02B
CDCRX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CDCRX vs. FSMAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDCRX is a Buy and FSMAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 36B vs. CDCRX (29.8M). FSMAX pays higher dividends than CDCRX: FSMAX (0.54) vs CDCRX (0.00). CDCRX was incepted earlier than FSMAX: CDCRX (13 years) vs FSMAX (14 years). CDCRX (2.89) is less costly to investors than FSMAX (0.04). CDCRX is a more actively managed with annual turnover of: 32.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than CDCRX: FSMAX (0) vs CDCRX (1000). FSMAX annual gain was more profitable for investors over the last year : 3.90 vs. CDCRX (-10.57). FSMAX return over 5 years is better than : 60.52 vs. CDCRX (10.99).
CDCRXFSMAXCDCRX / FSMAX
Total Expense Ratio1.950.045,571%
Annual Report Gross Expense Ratio2.890.048,257%
Fund Existence13 years14 years-
Gain YTD-3.194-7.98940%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets29.8M36B0%
Annual Yield % from dividends0.000.54-
Returns for 1 year-10.573.90-271%
Returns for 3 years-0.4632.38-1%
Returns for 5 years10.9960.5218%
Returns for 10 years-26.0859.20-44%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLGRX7.520.05
+0.67%
NYLI Winslow Large Cap Growth Class R3
OFSCX15.10N/A
N/A
Olstein Strategic Opportunities C
NAEFX66.28N/A
N/A
New Alternatives Investor
HNVRX37.51N/A
N/A
Harbor Small Cap Value Retirement
RSEYX12.29N/A
N/A
Columbia Global Value Inst2